Extracellular Vesicles Derived from Human CD24+ Dental Papilla Stem Cells Promote Vascularized Dental Pulp Regeneration
Biomolecules · 05.03.2026 · 16 (3) · 390
DOI: 10.3390/biom16030390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 05.03.2026. Verfasst von Jie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Engineering Research Center of Oral Translational Medicin…. Hauptthemen laut MEDLINE: CD24 Antigen, Dental Pulp, Regeneration, Stem Cells. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the Sichuan Science and Technology Program, the Research and Development Program of West China Hospital of Stomatology, Sichuan Uni-versity.
Abstract (Originalsprache)
Pulp necrosis remains a significant clinical challenge in dentistry, as current therapeutic approaches fail to achieve functional pulp regeneration. Extracellular vesicles (EVs), as crucial mediators of intercellular communication, offer new opportunities for regenerative strategies. In this study, we focus on CD24+ human dental papilla cells (CD24+ hDPCs), a functionally defined subpopulation previously characterized as having superior regenerative potential, and evaluate the regenerative potential of their derived EVs (CD24+ EVs) in pulp-like tissue regeneration. CD24+ EVs significantly enhanced the proliferation, migration, and osteo/odontogenic differentiation of human dental pulp stem cells (hDPSCs) and markedly promoted endothelial tube formation in vitro. In a treated dentin matrix (TDM)-based ectopic regeneration model, CD24+ EVs increased cellular accumulation within the regenerated tissue and robust angiogenesis, inducing the formation of well-organized, highly vascularized pulp-like tissue with dense cellular architecture and positive DSPP expression. Together, these findings suggest that CD24+ EVs concurrently enhance cell migration, odontogenic differentiation, and angiogenesis, and support a promising cell-assisted EV strategy grounded in functionally defined cellular subpopulations for pulp-like tissue regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Engineering Research Center of Oral Translational Medicine, Ministry of Education, National Engineering Laboratory for Oral Reg…
- Department of Oral & Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Förderung
- the National Key Research and Development Program of China
- the Sichuan Science and Technology Program
- the Research and Development Program of West China Hospital of Stomatology, Sichuan Uni-versity
- the State Key Clinical Department
- National Key Research and Development Program of China
- Sichuan Science and Technology Program
- Research and Development Program of West China Hospital of Stomatology, Sichuan University
- State Key Clinical Department
Zitieren
APA
Li, J., Chen, T., Liang, C., Lin, P., Tian, W., Liu, Z., & Liu, L. (2026). Extracellular Vesicles Derived from Human CD24+ Dental Papilla Stem Cells Promote Vascularized Dental Pulp Regeneration. Biomolecules, 16(3), 390. https://doi.org/10.3390/biom16030390
Vancouver
Li J, Chen T, Liang C, Lin P, Tian W, Liu Z, et al. Extracellular Vesicles Derived from Human CD24+ Dental Papilla Stem Cells Promote Vascularized Dental Pulp Regeneration. Biomolecules. 2026;16(3):390. doi:10.3390/biom16030390
BibTeX
@article{Li2026,
author = {Li, Jie and Chen, Tian and Liang, Cheng and Lin, Peini and Tian, Weidong and Liu, Zhi and Liu, Lei},
title = {Extracellular Vesicles Derived from Human CD24+ Dental Papilla Stem Cells Promote Vascularized Dental Pulp Regeneration},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {3},
pages = {390},
doi = {10.3390/biom16030390}
}
EUVIMED